Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 5 versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 5 versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
MANNITOL 5% vs OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into the extracellular fluid and vasculature, thereby reducing intracranial and intraocular pressure. It also increases renal tubular osmotic pressure, inhibiting water reabsorption and promoting diuresis.
Increases plasma osmolality, drawing water from tissues into the bloodstream, thereby reducing intracranial pressure and cerebral edema.
Intravenous infusion of 50-100 g (as a 5% solution) over 2-6 hours, typically 500-1000 mL, for osmotic diuresis; or for reduction of intracranial pressure, 1-2 g/kg IV over 30-60 minutes as a 15-25% solution.
Initial: 0.25–1 g/kg (25–100 mL of 10% solution) IV over 30–60 minutes. May repeat every 6–12 hours if needed. Typical adult dose: 50–100 g IV. Maximum: 2 g/kg per dose.
None Documented
None Documented
Terminal: 0.25–1.5 h (prolonged in renal impairment); clinical context: accumulates in renal failure, monitor serum osmolarity and renal function
Terminal half-life approximately 1.5 hours in normal renal function; prolonged in renal impairment (up to 36 hours in anuria).
Renal: 90% unchanged; biliary/fecal: negligible (<2%)
Primarily renal; >90% excreted unchanged in urine via glomerular filtration; <5% biliary/fecal.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic